A Pilot Study Employing Dehydroepiandrosterone (DHEA) in the Treatment of Chronic Fatigue Syndrome
| Autor: | Peter B. Himmel, Trina M. Seligman |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
endocrine system
medicine.medical_specialty education.field_of_study Disease onset business.industry Population Dehydroepiandrosterone Learned helplessness Emotional stress medicine.disease Gastroenterology Rheumatology Internal medicine polycyclic compounds medicine Chronic fatigue syndrome Anxiety In patient medicine.symptom business education human activities hormones hormone substitutes and hormone antagonists |
| Zdroj: | JCR: Journal of Clinical Rheumatology. 5:56-59 |
| ISSN: | 1076-1608 |
| DOI: | 10.1097/00124743-199904000-00004 |
| Popis: | Patients with chronic fatigue syndrome (CFS) frequently associate the disease onset with a period of high physical and/or emotional stress. Alterations in hypothalamic-pituitary adrenal axis (HPA) function have been demonstrated. Although Cortisol production in patients with CFS has proven to be low, Dehydroepiandrosterone (DHEA) production has not been measured. DHEA output may be altered in this population. The purpose of this uncontrolled, prospective, 6 month study of 23 white women, ages 35-55 was to identify CFS patients with suboptimal serum levels of DHEA-sulphate (DHEA-S), defined as DHEA-S |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|